Introduction
The considerable success of m-diamminedichloroplatinum(II) (cisplatin, DDP) in clinical oncol ogy has stimulated the synthesis and screening of a great variety of platinum coordination com pounds as potential antitumor agents.
We recently described a series of new platinum(II) complexes of benzoic-(bah), 3-methoxybenzoic (mbah) acid hydrazides (Dodoff et al., 1994) , and of 4-methoxy-(pmbah) and 4-chlorobenzoic (pcbah) acid hydrazides (Dodoff et al., 1995) . The interest in such ligands was pro voked by the data about various biological activi ties, including antitumor effect (Rutner et al., 1974) .
In order to evaluate the effect of the substitu tion of the aromatic acid hydrazides by cycloal kane ligands on the activity of platinum com plexes, a series of platinum coordination compounds with the hydrazide of cyclohexanecar boxylic acid was synthesized and characterized.
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Such ligands are known to exert biological activity (Offe et al., 1952; Yale et al., 1953) . The cytotoxic ity of these compounds on Friend leukemia (FL) cells in culture was compared with that of related complexes, previously reported (Dodoff et al., 1994; 1995) . Moreover, all platinum complexes containing chlorine anion ligands, were further characterized by their effect on macromolecular (DNA, RNA and protein) synthesis in FL cells, and tested for in vivo antitumor activity against L1210 leukemia. (1988) . The hydrazide of cyclohexanecarboxylic acid (chcah) was synthesized following Olsen et al. (1948) . The remaining chemicals were AR grade products.
Materials and Methods

Chemicals
Synthesis
The procedures for preparation of platinum complexes of chcah were analogous to those de scribed in Dodoff et al. (1994) , which were based on the method of Kharitonov et al. (1975) .
[Pt(chcah)2Cl2J (I C, 19.77; H, 4.03; N, 9.88; Cl, 16.68; Pt, 45.88. Found: C, 20.21; H, 4.00; N, 9.72; Cl, 16.20; Pt, 45.25 .
[ (1975) . Solu tions of 0.250 g (0.60 mmol) of K2[PtCl4] in 5 ml water and 1.5 g (12.60 mmol) KBr in 3 ml water (respectively 0.418 g (2.52 mmol) of K1 in 2 ml water) were mixed and heated on a water bath (20 min at 60-70 °C for KBr solution and 20 min at 35-40 °C for K1 solution). A solution of 0.256 g (1.80 mmol) of chcah in 15 ml water was added while stirring to a solution of the corresponding K2[PtX4], A light yellow precipitate for the bromo-complex, or a dark yellow precipitate for the iodo-complex were immediately formed. After 3 h they were filtered, washed with water and etha nol. The complexes were recrystallized from meth anol: tetrahydrofuran 1:5. Yields: III -0.310 g (80%); IV -0.360 g (81%), m.r. for III 235-240 °C (dec.); m.r. for IV 215-225 °C (dec.).
Anal. Calc, for C 14H28Br2N40 2Pt: C, 26.30; H, 4.41; N, 8.76; Br, 25.00; Pt, 30.52. Found: C, 26, 76; H, 4.54; N, 8.53; Br, 24.53; Pt, 30.87 .
Anal. Calc, for C 14H28I2N40 2Pt: C, 22.93; H, 3.85; N, 7.64; Pt, 26.60. Found: C, 22.68; H, 4.06; N, 7.72; Pt, 26.16 .
Analyses
The elemental analyses were performed by rou tine microanalytical procedures (Institute of Or ganic Chemistry, Bulgarian Academy of Sciences).
Melting ranges were determined with a Boetius heating-plate microscope.
!H NMR spectra were registered on a Bruker WM 250 spectrometer at 250 MHz in DMSO-d6 solution using TMS as internal standard. D20 ex change was applied to confirm the assignment of nitrogen-bound protons.
Infrared spectra were recorded on a Bruker ISF-113V spectrophotometer in Csl disks (4000-400 cm"1), (400-150 cm -1).
In vitro cytotoxic assay
FL cells (clone F4N) were grown in Dulbecco's modified Eagle medium, supplemented with 10% calf serum, under 5% C 0 2 atmosphere at 37 °C. The cultures were passed every day at a concentra tion of 5 x l0 5 cells/ml.
The compounds studied were dissolved immedi ately before use in DMSO to obtain stock solution of various concentrations. Each of these solutions was then used at 1 % concentration in the experi ments. Control cells were incubated in the pres ence of 1% DMSO. The final concentration of DMSO in the medium did not affect the viability of the cells.
Exponentially growing cells were incubated in triplicate with increasing concentrations of test compounds for 24, 48 and 72 h, and counted there after hemocytometrically. The number of dead cells was determined by staining with trypan blue. The mean of two independent determinations was calculated. The 50% inhibitory dose (IC50) was de fined as drug concentration that reduced the number of living cells by 50%.
Macromolecular synthesis assay
The macromolecular synthesis determination was essentially carried out as described (Grancharov et al., 1988) .
FL cells at a concentration of 0.5 xlO6 cells/ml were incubated in duplicate for 24 h at 37 °C with incremental concentrations of platinum com Aliquots of cell suspension were pipetted on Whatman filter paper disks, the acid-soluble radio activity was extracted with cold trichloroacetic acid (5%), and the incorporated activity deter mined by scintillation counting. The average value of two independent experiments was calculated. 
In vivo antitumor evaluation
The method of European Organisation Re search of Treatment of Cancer (EORTC) screen ing group (1972) was used to determine the toxic ity and therapeutic doses of the compounds.
The complexes were tested against L1210 leuke mia. BDFt mice (20-22 g) were given i.p. L1210 cells (lx lO 5, suspended in 0.1 ml of saline). After 24 h (day 1) of tumor transplantation the com pounds were administered i.p. as saline suspen sions at doses and schedules shown in Table IV .
The antitumor activity was defined as percent increased survival time determined by dividing the mean survival time of treated animals by that of control animals (% T/C).
The statistical analysis was performed using the Student's t-test.
Results and Discussion
The formulae, analytical and some physical data of the newly synthesized complexes are given in the section Materials and Methods. The complexes are yellow-coloured solids that decompose upon heating. They are soluble in DMF or DMSO, and are practically insoluble in water.
Infrared spectral data for the ligand and com plexes as Csl disks are collected in Table 1 .1. The bands in the range of absorptions of the v(NH2) and v(NH) stretching vibrations in the spectra of the complexes were shifted to lower frequency as compared to those of the free ligand. This is indic ative of a coordination of the hydrazide to the platinum via the NH2 group. In the far IR range of the spectra were registered two bands which are indicative of a c/s-configuration of the complexes. Some of the weak bands in the range of 565-486 cm-1 in the spectra of the complexes could tenta tively be ascribed to P t-N stretchings.
The 'H NMR spectral data (DMSO-d6) of the free ligand and the respective platinum complexes are presented in Table 1 .2. In the spectra of the hydrazide of the cyclohexanecarboxylic acid, a complicated multiplet was observed, due to the methylene protons at the cyclohexane ring. A clear triplet of triplets was registered in the range of 1.98-2.09 ppm because of the existing a-CH proton of the cyclohexane residue. Signals for NH2 and NH groups were observed at 4.10 and 8.85 ppm. respectively. For all complexes, the signal of the NH2 protons was significantly shifted downfields, and those of NH protons were much less moved in comparison with the free ligand. This shows that chcah coordinate to platinum via the NH2 group. In the spectra of the platinum com plexes no significant shift of the signals due to the cyclohexyl residue was registered.
Similar IR and !H NMR spectral data have been reported in our previous papers for platinum com plexes of differently substituted benzoic acid hydrazides (Dodoff et al., 1994; 1995) .
The elemental analysis and spectroscopic data are in accordance with the structures for the com plexes shown in Fig. 1 .
I X=C1 II III X=Br IV X=I
In Table II be concluded that the complexes with cycloalkane ligands are less toxic than platinum compounds with aromatic ligands. Thus, after 72 h incubation with the new complexes the FL cells seemed to recover from their inhibitory activity. Further, we examined the macromolecular syn thesis inhibition in FL cells and the in vivo antitu mor activity against L1210 leukemia of selected new as well as previously synthesized platinum co ordination compounds (Dodoff et al., 1994; 1995) containing chlorine as acid ligands. Complexes with bromine or iodine anions were not included since they were inactive against experimental tu mors (unpublished results).
FL cells were incubated for 24 h with the com pounds, and thereafter [3H]thymidine, [14C]uridine or [14C]leucine was added to follow DNA, RNA or protein biosynthesis, respectively. Drug concentrations, required to reduce by 50% precur- Table III sor incorporation into FL cells, are presented in Table III . As a whole, the macromolecular synthe sis inhibition profile followed that obtained by the cell-growth assay (Table II; Comparing the data of Tables II, III and IV, and those reported by us previously (Dodoff et al., Table IV . Antitumor activity of platinum(II) com plexes in L1210 leukemia. 1994; 1995), some important conclusions could be drawn: First, there is no correlation between the in vitro cytotoxic effect and the in vivo antitumor activity. Thus, agent II exhibiting the highest antitumor ac tivity, showed a moderate cytotoxicity against FL cells in culture, comparable with that of the in active compound I.
Secondly, there is a relationship between the in vitro inhibition profile of DNA, RNA and protein synthesis, and the antineoplastic activity of the compounds. Agents with activity towards L1210 leukemia displayed a macromolecular synthesis in hibition pattern similar to that of cisplatin.
Thirdly, regarding the structure-activity relation ship, it is evident that only agents containing an ammine ligand exhibited antitumor activity. This finding is in accordance with the observed require ment of at least one ammine ligand for the proper binding of a clinically active platinum agent to DNA, as reported recently by Takahara et al. (1995) . The substitution of the aromatic ring in the complexes by a cycloalkane residue increased sig nificantly the antineoplastic activity. Thus, com plex II with chcah as a ligand produced the highest effect with L1210 leukemia, while the relative agent VI was inactive.
